AI-assisted insulin pump study for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of type 1 diabetes.
- You are between 14 and 65 years old.
- Your most recent HbA1c (average blood sugar over 3 months) is less than 11%.
- You've had type 1 diabetes for at least 3 months, and you've been using either multiple daily insulin injections or an insulin pump for at least 3 months.
- You are willing to wear a study device (like a pump or sensor) at all times and use specific fast-acting insulins (aspart or lispro).
- You can do at least one blood sugar check by fingerstick each day and upload data from the device.
- You are willing to learn about diabetes self-management and how to use the study device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests an insulin pump to help people with type 1 diabetes keep their blood sugar in a healthy range more of the time. You'll wear the pump and share weekly data with the study team.
This study uses artificial intelligence to analyze glucose monitor data from people with type 1 diabetes. The goal is to find patterns that could improve care and treatment.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.